JPH03112484U - - Google Patents
Info
- Publication number
- JPH03112484U JPH03112484U JP2050290U JP2050290U JPH03112484U JP H03112484 U JPH03112484 U JP H03112484U JP 2050290 U JP2050290 U JP 2050290U JP 2050290 U JP2050290 U JP 2050290U JP H03112484 U JPH03112484 U JP H03112484U
- Authority
- JP
- Japan
- Prior art keywords
- down tube
- cross member
- front ends
- pipe
- motorcycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002828 fuel tank Substances 0.000 description 1
Landscapes
- Automatic Cycles, And Cycles In General (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2050290U JPH03112484U (en, 2012) | 1990-03-02 | 1990-03-02 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2050290U JPH03112484U (en, 2012) | 1990-03-02 | 1990-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03112484U true JPH03112484U (en, 2012) | 1991-11-18 |
Family
ID=31523595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2050290U Pending JPH03112484U (en, 2012) | 1990-03-02 | 1990-03-02 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03112484U (en, 2012) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8796427B2 (en) | 2008-01-24 | 2014-08-05 | Novo Nordisk A/S | Humanized anti-human NKG2A monoclonal antibody |
US8901283B2 (en) | 2006-06-30 | 2014-12-02 | Novo Nordisk A/S | Anti-NKG2A antibodies and uses thereof |
US9512228B2 (en) | 2011-06-17 | 2016-12-06 | Novo Nordisk A/S | Selective elimination of erosive cells |
-
1990
- 1990-03-02 JP JP2050290U patent/JPH03112484U/ja active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8901283B2 (en) | 2006-06-30 | 2014-12-02 | Novo Nordisk A/S | Anti-NKG2A antibodies and uses thereof |
US9683041B2 (en) | 2006-06-30 | 2017-06-20 | Novo Nordisk A/S | Anti-NKG2A antibodies and uses thereof |
US8796427B2 (en) | 2008-01-24 | 2014-08-05 | Novo Nordisk A/S | Humanized anti-human NKG2A monoclonal antibody |
US9422368B2 (en) | 2008-01-24 | 2016-08-23 | Novo Nordisk A/S | Humanized anti-human NKG2A monoclonal antibody |
US9512228B2 (en) | 2011-06-17 | 2016-12-06 | Novo Nordisk A/S | Selective elimination of erosive cells |